{
    "code": "02024931",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024931",
    "time": "2019-03-15 03:05:44",
    "許可證字號": "衛署藥輸字第024931號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/12\/03",
    "發證日期": "97\/12\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202493107",
    "中文品名": "斥消靈錠 2 毫克",
    "英文品名": "Rapamune Tablets 2 mg",
    "適應症": "1.與CYCLOSPORINE及皮質類固醇合併使用來預防病人腎臟移植後之器官排斥。2.若病人有低度或中度免疫上的危險於移植後2到4個月，可以逐步停止使用CYCLOSPORINE而斥消靈 (SIROLIMUS)應增加劑量至到達血中建議濃度。",
    "劑型": "119糖衣錠",
    "包裝": "2~1000錠鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "SIROLIMUSNANOSYSTEMSDISPERSION"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0929101100  美商惠氏藥廠（亞洲）股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F230024000  Pfizer Ireland Pharmaceuticals",
        "製造廠廠址": "LITTLE CONNELL NEWBRIDGE CO. KILDARE, IRELAND",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6133080025  輝瑞生技股份有限公司新竹廠",
            "製造廠廠址": "新竹縣新豐鄉中崙村中崙290-1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "分包裝廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200039620",
            "成分名稱": "SIROLIMUS NANOSYSTEMS DISPERSION",
            "含量描述": "SIROLIMUS 100% 2MG,POLOXAMER 188 1 MG",
            "含量": "3.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Rapamune Tablets 0.5 1 2mg-56.6x38.4cm-20181123 Hi-108-01-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024931&Seq=001&Type=9"
        },
        {
            "title": "Rapamune Tablets 2 mg foil and carton-104-09-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024931&Seq=001&Type=8"
        }
    ]
}